Greg Roche, CEO of Distalmotion, has over two decades of leadership in the Medtech industry, specializing in laparoscopic surgery, endoscopic visualization and surgical robotics. Since joining Distalmotion in December 2023, he has been leading the company’s global commercial expansion of the DEXTER® Robotic Surgery System.

Before joining Distalmotion, Roche was CEO of avateramedical, adding to his leadership and experience within soft-tissue robotic technologies. Prior to this, he served as Global President, Robotics and Technology at Zimmer Biomet, where he led the successful global launch of the ROSA® Robotic Knee System and delivered above-market growth, in part by developing innovative business models tailored to the unique demands of Ambulatory Surgical Centers (ASC’s). Earlier in his career, beginning in the early 2000s, Roche held multiple US commercial and leadership roles at Stryker.